Unlocking the pathways of endocrine resistance

Date

07 Oct 2016

Session

New developments in the management of ER-positive metastatic breast cancer

Presenters

Giuseppe Curigliano

Authors

G. Curigliano

Author affiliations

  • Drug Development, Istituto Europeo di Oncologia, 20141 - Milano/IT
More

Resources

Reserved to ESMO members
View the presentation

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings